Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1207139

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1207139

Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

The global pediatric vaccines market size reached US$ 34.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 54.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Pediatric vaccines or immunizations refer to medical supplies that create immunity in infants, children and adolescents. They are utilized for the prevention, treatment and management of diseases and are commonly available in multivalent and monovalent variants. These vaccines are commonly used in pediatric oncology, cardiology, critical care, and pulmonology departments. Pediatric vaccines assist in protecting children from various serious illnesses, such as polio, measles, brain swelling, paralysis, diarrhea and hepatitis. These vaccines are safe, effective, promote a healthier life and protect against infectious or noninfectious diseases.

Pediatric Vaccines Market Trends:

  • The increasing number of births and the rising prevalence of various pediatric diseases represents the key factor primarily driving market growth. Additionally, the increasing need to promote public health and the widespread adoption of pediatric vaccines as a cost-effective means of advancing global welfare is also propelling the market growth. In line with this, the development of efficacious and safe vaccination that eliminates and decreases dangerous diseases that spread from child to child is favoring the market growth. Furthermore, various product innovations, such as the introduction of new pediatric vaccines that aid in the treatment of adolescents and children with relapsing forms of multiple sclerosis (RMS), are providing a considerable boost to the market growth. Additionally, the increasing demand for conjugate vaccines that consist of antigens and have the ability to elicit immunological memory and reduce asymptomatic carriage of the bacteria is positively impacting the market growth. Apart from this, growing awareness regarding early disease diagnosis and prevention, extensive research and development (R&D) activities and implementation of various government initiatives to promote accurate and timely administration of pediatric vaccination are anticipated to drive the market further toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology and application.

Breakup by Type:

  • Multivalent
  • Monovalent

Breakup by Technology:

  • Conjugate
  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Others

Breakup by Application:

  • Infectious Disease
  • Cancer
  • Allergy
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.

Key Questions Answered in This Report:

  • How has the global pediatric vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pediatric vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pediatric vaccines market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR1323A611_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pediatric Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multivalent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Monovalent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Conjugate
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Live Attenuated
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Inactivated
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subunit
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Toxoid
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Allergy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Med Private Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Daiichi Sankyo Company Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 GSK plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Panacea Biotec Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinovac Biotech Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
Product Code: SR1323A611_Report

List of Figures

  • Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
  • Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
  • Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pediatric Vaccines Market: Competitive Structure
  • Table 7: Global: Pediatric Vaccines Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!